Table 3 Numbers of patients eligible for CVD risk assessment, numbers assessed and numbers identified as eligible for drug treatments
Practice | Eligible for CVD risk assessment* | CVD risk calculated (% of those eligible for assessment) | Identified as eligible for aspirin (% of those eligible for assessment) | Identified as eligible for antihypertensive (% of those eligible for assessment) | Identified as eligible for statin (% of those eligible for assessment) | Identified as eligible for at least one treatment (% of those eligible for assessment) |
|---|---|---|---|---|---|---|
PN1 | 103 | 60 (58.3%) | 40 (38.8%) | 22 (21.4%) | 43 (41.7%) | 44 (42.7%) |
PN2 | 128 | m (69.5%) | 65 (50.8%) | 29 (22.7%) | 69 (53.9%) | 70 (54.7%) |
PN3 | 164 | 88 (53.7%) | 70 (42.7%) | 52 (31.7%) | 76 (46.3%) | m (46.3%) |
PN4 | 203 | 133 (65.5%) | 98 (48.3%) | m (33.0%) | 105 (51.7%) | 107 (52.7%) |
All project nurse practices | 598 | m (61.9%) | 273 (45.7%) | 170 (28.4%) | 293 (49.0%) | 297 (49.7%) |
Info1 | 175 | 75 (42.9%) | 51 (29.1%) | 36 (20.6%) | 57 (32.6%) | 57 (32.6%) |
Info2 | 288 | 54 (18.8%) | 38 (13.2%) | 22 (7.6%) | 43 (14.9%) | 43 (14.9%) |
All information only practices | 463 | 129 (27.9%) | 89 (19.2%) | 58 (12.5%) | 100 (21.6%) | 100 (21.6%) |
All practices | 1061 | 499 (47.0%) | 362 (34.1%) | 228 (21.5%) | 393 (37.0%) | 397 (37.4%) |